vs
Alpha Cognition Inc.（ACOG）与ADMA BIOLOGICS, INC.（ADMA）财务数据对比。点击上方公司名可切换其他公司
ADMA BIOLOGICS, INC.的季度营收约是Alpha Cognition Inc.的49.8倍（$139.2M vs $2.8M）。ADMA BIOLOGICS, INC.净利率更高（35.5% vs -245.5%，领先281.0%）。ADMA BIOLOGICS, INC.自由现金流更多（$34.6M vs $-7.1M）
ADMA生物制剂公司是一家专注于研发、生产及商业化特种血浆来源免疫球蛋白疗法的生物制药企业，主要面向美国市场，为原发性免疫缺陷及其他免疫相关疾病患者、医护人员和医疗机构提供免疫健康领域的治疗方案。
ACOG vs ADMA — 直观对比
营收规模更大
ADMA
是对方的49.8倍
$2.8M
净利率更高
ADMA
高出281.0%
-245.5%
自由现金流更多
ADMA
多$41.6M
$-7.1M
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $2.8M | $139.2M |
| 净利润 | $-6.9M | $49.4M |
| 毛利率 | — | 63.8% |
| 营业利润率 | -283.7% | 45.1% |
| 净利率 | -245.5% | 35.5% |
| 营收同比 | — | 18.4% |
| 净利润同比 | — | -55.9% |
| 每股收益（稀释后） | $-0.10 | $0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACOGADMA
| Q4 25 | $2.8M | $139.2M | ||
| Q3 25 | $2.8M | $134.2M | ||
| Q2 25 | $1.7M | $122.0M | ||
| Q1 25 | $2.9M | $114.8M | ||
| Q4 24 | — | $117.5M | ||
| Q3 24 | — | $119.8M | ||
| Q2 24 | — | $107.2M | ||
| Q1 24 | — | $81.9M |
净利润ACOGADMA
| Q4 25 | $-6.9M | $49.4M | ||
| Q3 25 | $-1.3M | $36.4M | ||
| Q2 25 | $-10.5M | $34.2M | ||
| Q1 25 | $-2.0M | $26.9M | ||
| Q4 24 | — | $111.9M | ||
| Q3 24 | — | $35.9M | ||
| Q2 24 | — | $32.1M | ||
| Q1 24 | — | $17.8M |
毛利率ACOGADMA
| Q4 25 | — | 63.8% | ||
| Q3 25 | — | 56.3% | ||
| Q2 25 | 96.7% | 55.1% | ||
| Q1 25 | 99.6% | 53.2% | ||
| Q4 24 | — | 53.9% | ||
| Q3 24 | — | 49.8% | ||
| Q2 24 | — | 53.6% | ||
| Q1 24 | — | 47.8% |
营业利润率ACOGADMA
| Q4 25 | -283.7% | 45.1% | ||
| Q3 25 | -187.0% | 38.0% | ||
| Q2 25 | -346.1% | 35.1% | ||
| Q1 25 | -125.9% | 30.4% | ||
| Q4 24 | — | 32.6% | ||
| Q3 24 | — | 33.1% | ||
| Q2 24 | — | 36.6% | ||
| Q1 24 | — | 26.7% |
净利率ACOGADMA
| Q4 25 | -245.5% | 35.5% | ||
| Q3 25 | -46.4% | 27.1% | ||
| Q2 25 | -632.7% | 28.1% | ||
| Q1 25 | -68.5% | 23.4% | ||
| Q4 24 | — | 95.2% | ||
| Q3 24 | — | 30.0% | ||
| Q2 24 | — | 29.9% | ||
| Q1 24 | — | 21.7% |
每股收益（稀释后）ACOGADMA
| Q4 25 | $-0.10 | $0.20 | ||
| Q3 25 | $-0.30 | $0.15 | ||
| Q2 25 | $-0.65 | $0.14 | ||
| Q1 25 | $-0.13 | $0.11 | ||
| Q4 24 | — | $0.45 | ||
| Q3 24 | — | $0.15 | ||
| Q2 24 | — | $0.13 | ||
| Q1 24 | — | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $66.0M | $87.6M |
| 总债务越低越好 | — | $72.1M |
| 股东权益账面价值 | $62.5M | $477.3M |
| 总资产 | $79.7M | $624.2M |
| 负债/权益比越低杠杆越低 | — | 0.15× |
8季度趋势，按日历期对齐
现金及短期投资ACOGADMA
| Q4 25 | $66.0M | $87.6M | ||
| Q3 25 | $35.4M | $61.4M | ||
| Q2 25 | $39.4M | $90.3M | ||
| Q1 25 | $45.5M | $71.6M | ||
| Q4 24 | — | $103.1M | ||
| Q3 24 | — | $86.7M | ||
| Q2 24 | — | $88.2M | ||
| Q1 24 | — | $45.3M |
总债务ACOGADMA
| Q4 25 | — | $72.1M | ||
| Q3 25 | — | $72.4M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $72.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ACOGADMA
| Q4 25 | $62.5M | $477.3M | ||
| Q3 25 | $33.9M | $431.2M | ||
| Q2 25 | $31.9M | $398.3M | ||
| Q1 25 | $40.8M | $373.4M | ||
| Q4 24 | — | $349.0M | ||
| Q3 24 | — | $231.9M | ||
| Q2 24 | — | $188.3M | ||
| Q1 24 | — | $153.7M |
总资产ACOGADMA
| Q4 25 | $79.7M | $624.2M | ||
| Q3 25 | $46.3M | $568.7M | ||
| Q2 25 | $45.1M | $558.4M | ||
| Q1 25 | $48.6M | $510.6M | ||
| Q4 24 | — | $488.7M | ||
| Q3 24 | — | $390.6M | ||
| Q2 24 | — | $376.4M | ||
| Q1 24 | — | $350.9M |
负债/权益比ACOGADMA
| Q4 25 | — | 0.15× | ||
| Q3 25 | — | 0.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.9M | $35.6M |
| 自由现金流经营现金流 - 资本支出 | $-7.1M | $34.6M |
| 自由现金流率自由现金流/营收 | -252.6% | 24.8% |
| 资本支出强度资本支出/营收 | 5.3% | 0.8% |
| 现金转化率经营现金流/净利润 | — | 0.72× |
| 过去12个月自由现金流最近4个季度 | $-20.7M | $27.8M |
8季度趋势，按日历期对齐
经营现金流ACOGADMA
| Q4 25 | $-6.9M | $35.6M | ||
| Q3 25 | $-5.3M | $13.3M | ||
| Q2 25 | $-6.1M | $21.1M | ||
| Q1 25 | $-2.0M | $-19.7M | ||
| Q4 24 | — | $50.2M | ||
| Q3 24 | — | $25.0M | ||
| Q2 24 | — | $45.6M | ||
| Q1 24 | — | $-2.2M |
自由现金流ACOGADMA
| Q4 25 | $-7.1M | $34.6M | ||
| Q3 25 | $-5.4M | $-1.1M | ||
| Q2 25 | $-6.1M | $18.7M | ||
| Q1 25 | $-2.1M | $-24.4M | ||
| Q4 24 | — | $47.5M | ||
| Q3 24 | — | $24.0M | ||
| Q2 24 | — | $43.6M | ||
| Q1 24 | — | $-4.6M |
自由现金流率ACOGADMA
| Q4 25 | -252.6% | 24.8% | ||
| Q3 25 | -188.8% | -0.8% | ||
| Q2 25 | -370.9% | 15.3% | ||
| Q1 25 | -72.0% | -21.2% | ||
| Q4 24 | — | 40.4% | ||
| Q3 24 | — | 20.0% | ||
| Q2 24 | — | 40.7% | ||
| Q1 24 | — | -5.6% |
资本支出强度ACOGADMA
| Q4 25 | 5.3% | 0.8% | ||
| Q3 25 | 2.6% | 10.7% | ||
| Q2 25 | 0.5% | 2.0% | ||
| Q1 25 | 2.2% | 4.1% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | — | 1.9% | ||
| Q1 24 | — | 2.9% |
现金转化率ACOGADMA
| Q4 25 | — | 0.72× | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.62× | ||
| Q1 25 | — | -0.73× | ||
| Q4 24 | — | 0.45× | ||
| Q3 24 | — | 0.70× | ||
| Q2 24 | — | 1.42× | ||
| Q1 24 | — | -0.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
